Nossos Associados

Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies, with annual revenues greater than $1.8 billion, employees in more than 60 countries, and more than 10,000 employees worldwide.


(Toxicology, Research Products, Analytical Services)

  • Managed 443 compound development programs (>250 IND/CTA enabling), with over 100 different sponsors, which led to 41 IND/CTA applications in 2009
  • Performed best-in-class productivity cycle times: FIA to FIH in 22 weeks
  • Dedicated Capacity Agreements with several major pharma customers
  • Greater than 2.5M sq ft of research space

(Clinical Pharmacology, Clinical, Central Labs)

  • Supported 50% of latest breakthrough cancer treatments
  • Supported development of the top 25 currently marketed medicines
  • 70% of clinical programs on or ahead of enrollment timelines
  • Broad-based, scalable and market-leading, Biomarker capability
  • 99% of samples received within stability
  • 145 million laboratory tests; 83,000 investigator sites; 100 countries
  • Eight Clinical Pharmacology units with ~500 beds


  • Results-driven reimbursement support for >60% of the biologics market
  • Designed and managed world’s largest safety registry ever – iPledge
  • Team of experts dedicated to risk management and Pharmacovigilance
  • Bi-coastal call center capabilities to deliver patient and physician support